WORLD CANCER DAY
On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.
The pact between the drug firm and the group is aimed at giving equitable access to treatments and vaccines for people in disadvantaged parts of the world.
Sanofi has made a new five-year, $25m partnership agreement with the World Health Organization (WHO) to fight Neglected Topical Diseases (NTD); and eliminate sleeping sickness by 2030.
CTI Clinical Trial and Consulting Services has expanded its global reach by purchasing Clinart, a full-service CRO with precence in the MENA region.
LomÉ Initiative Signing
Although control measures are applied, falsified medicines are present in the supply chain in Niger, with solutions requiring cross-country collaboration, says the country’s Ministry of Health.
LOMÉ INITIATIVE SIGNING
As African countries look to secure their supply chains, head of the WHO’s team on fighting falsified and substandard medicine speaks about how to ‘demand quality’.
With efforts to tackle fake drugs in Africa increasing, the WHO's director-general speaks on the need to shorten the supply chain with local manufacturing.
LomÉ Initiative Signing
Heads of state of seven African countries met in Lomé, Togo, to sign the Lomé Initiative, a political declaration to tackle fake medicine distribution on the continent.
Competitive costs, improving infrastructure, and a high burden of disease are increasing the demand for clinical research in Africa, says CRO, which has partnered with a US-based firm to expand its service offerings.
Navitas has acquired KAI Research to expand its trial site footprint in North America and Africa as well as bolster its ability to manage clinical trials in a number of research areas.
Merck KGaA says it will provide technology and training to a local team in Sub-Saharan Africa, to help establish a dedicated human vaccine manufacturing facility.
Researchers in sub-Saharan Africa have developed a plug-and-play lab-on-a-chip - a ‘nontraditional approach’ to a global problem, says AAPS plenary speaker.
Indian drugmaker Strides Shasun has bolstered its generics manufacturing network by acquiring stakes in Kenya’s Universal Corporation and Australia’s Generic Partners Holdings.
South African Police shut down three counterfeit drug making plants last weekend in an INTERPOL-co-ordinated operation that seized 150 tonnes of fake medicines.
Technology transfer is the first step to bringing pharma investments to Africa, says the African Regulatory Network (ARN).
Aid agencies in countries hardest hit by Ebola rely on manual, paper-based data collection according to one expert who says CDISC templates and mobile data capture would help.
GSK says it intends to build five new drug manufacturing as part of a £130m ($215m) investment in sub-Saharan Africa.
Australia’s largest clinical CRO Novotech has expanded its clinical services with a new office in Johannesburg, South Africa to deal with increasing sponsor demand.
Sanofi has begun construction of a $95m (€70m) dry and liquid pharmaceutical plant in Sidi Abdellah, Algeria.
Full-Service CRO PSI is expanding into Italy, South Africa and India as part of a push to gain a more global presence for clients.
German CMO Rentschler landed APN311 production deal thanks to location and cell culture based manufacturing skills according to BioPharma Apeiron Biologics.
Simple steps to secure Rwanda’s pharma supply chain may serve as an example for other larger African countries looking to curtail the spread of falsified or substandard drugs, experts say.
A push to root out antimalarial counterfeit drugs in Ghana will begin later this year or early 2014 as part of a pilot project to test an FDA-developed counterfeit detector.
‘Unfair competition’ from Asian drugmakers and the prevalence of counterfeits are among the challenges facing African manufacturers according to a new pan-African industry group set on fostering local production.
Regional manufacturers’ associations have set up a pan-African organisation designed to promote local drug production.
WAPMA and PMGMAN are calling on African Governments to pump more money into R&D in order to boost the continent’s pharmaceutical manufacturing sector.
Drug quality in Mozambique looks set to improve following the creation of a national QA/QC testing laboratory.
Sub-Saharan Africa is a “very attractive market” because of local leaders’ new focus on supporting generics makers, according to Sandoz.
USP plans to open a laboratory and training centre in Ghana to strengthen quality control and offer services in sub-Saharan Africa.
UTi Worldwide reported higher pharmaceutical volumes in the fourth quarter on new business wins and increased client activity.
More than four-fifths of anti-malarials sampled in Nigeria failed to meet USP specifications for one of the APIs, researchers found.
Generics and API maker Ranbaxy has opened a plant in Casablanca, Morocco in a bid to strengthen its foothold in the “increasingly important” North African drugs market.
SE Asia likely source of fake anti-malarials in Africa; study
Counterfeit anti-malarials containing the Viagra API were probably manufactured in Southeast Asia, researchers found.
IMCD buys pharma supplier Organotec in Italy
Netherlands-based IMCD has bought Italian fine chemicals supplier Organotec Srl to expand its pharma actives across Europe.
UNIDO and AUC says Big Pharma can support drugmaking in Africa through partnering
The United Nations Industrial Development organisation (UNIDO) says it will help foster pharmaceutical manufacturing in Africa and has called on international Pharmas to do likewise.
Merck South Africa, a subsidiary of German pharma giant, Merck KGaA, has sold its Merck Pharmaceutical Manufacturing (MPM) operations in Johannesburg to investment firm, Nkunzi Investment Holdings.
Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa.
Cadila JV to set up plant in Rwanda
CSM GlobalPharma has announced plans to invest $65m in a manufacturing facility in Kigali, Rwanda in collaboration with the Rwandan Development Board (RDB).
USP launches drug quality programme in sub-Saharan Africa
The United States Pharmacopeoia (USP) will help regulators in sub-Saharan Africa ensure drug quality in a new scheme designed to boost testing and analysis capacity.
Ranbaxy to supply ARVs to South Africa in 2-year deal
A Ranbaxy Laboratories’ joint venture has been awarded a two-year contract to supply antiretrovirals (ARV) to the South African government.
Indoco expands deal with Aspen
Indian CRAMS group Indoco Remedies announces expansion of manufacturing deal with Aspen Pharmacare.
Aspen op income up 20%
Aspen Pharmacare increased operating profit by 20 per cent to R2.6bn ($368m) in its full year results.
Cipla looking at 25% Cipla Medpro investment
Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.
Adcock plans expansions & acquisitions to drive growth
Adcock Ingram recorded an 11 per cent rise in profit in the first half of 2010 and is looking to continue this upwards trend through manufacturing expansions, plus local and overseas acquisitions.
Contract services giant Quintiles has continued its expansion in Africa with a new clinical research services office in Nairobi, Kenya.
Almost half of antimalarials in Senegal are substandard; study
Almost half of antimalarials in Senegal are substandard, according to a USP study which will be used by local regulators to focus efforts on high-risk products, brands and geographies.
WHO endorses African clinical trial registry
The Pan-African Clinical Trials Registry (PACTR) has become the first such database to be endorsed by the WHO, providing the world with access to studies on the continent and improving efficiencies.
Quintiles: Africa is the next drug development frontier
Quintiles has targeted Africa as the next non-traditional area to develop new medicines and the opening of its office in Ghana, which is now fully operational, is a major step in this process, Gillian Corken, head of Quintiles in Africa, told Outsourcing-Pharma.
ACRO hopes to boost research in Africa
South-Africa based ACRO is aiming at building partnerships across its home continent, according to its MD who told Outsourcing-Pharma of its ambition to have more local people performing research.
Quintiles sets up in Ghana to boost recruitment pool
UK CRO Quintiles Transnational has set up an office in Accra, Ghana in a move it claims allows it to recruit trial participants from sub-Saharan Africa’s estimated 760m residents.